Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allan Saul

Showing results (21-30 of 122) with videos related to

Pageof 13
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|August 6, 2005
Determining residual host cell antigen levels in purified recombinant proteins by slot blot and scanning laser densitometryAaron P Miles, Daming Zhu, Allan Saul
Statistics in Biopharmaceutical Research|September 12, 2009
Robust Non-inferiority Tests for Potency of a Test Drug Against a Reference Drug: (To appear in Statistics in Biopharmaceutical Research )Michael P Fay, Farzad Noubary, Allan Saul
Plos Neglected Tropical Diseases|January 6, 2017
A Systematic Review of the Incidence, Risk Factors and Case Fatality Rates of Invasive Nontyphoidal Salmonella (iNTS) Disease in Africa (1966 to 2014)Ifeanyi Valentine Uche, Calman A MacLennan, Allan Saul
Acta Crystallographica. Section D, Biological Crystallography|March 25, 2004
Crystallization and preliminary X-ray analysis of the Plasmodium vivax sexual stage 25 kDa protein Pvs25, a transmission-blocking vaccine candidate for malariaAjay K Saxena, Allan Saul, David N Garboczi
Bioconjugate Chemistry|November 10, 2015
Click Chemistry Applied to the Synthesis of Salmonella Typhimurium O-Antigen Glycoconjugate Vaccine on Solid Phase with Sugar RecyclingGiuseppe Stefanetti, Allan Saul, Calman A MacLennan, et al.
Protein Expression and Purification|June 20, 2002
Large-scale purification and characterization of malaria vaccine candidate antigen Pvs25H for use in clinical trialsAaron P Miles, Yanling Zhang, Allan Saul, et al.
BMC Infectious Diseases|June 2, 2022
The impact of three progressively introduced interventions on second wave daily COVID-19 case numbers in Melbourne, AustraliaAllan Saul, Nick Scott, Tim Spelman, et al.
High-Throughput|June 12, 2020
Intra-Laboratory Evaluation of Luminescence Based High-Throughput Serum Bactericidal Assay (L-SBA) to Determine Bactericidal Activity of Human Sera against <i>Shigella</i>Omar Rossi, Eleonora Molesti, Allan Saul, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 27, 2002
High diversity and rapid changeover of expressed var genes during the acute phase of Plasmodium falciparum infections in human volunteersJennifer Peters, Elizabeth Fowler, Michelle Gatton, et al.
Journal of Immunological Methods|May 1, 2019
Development of FAcE (Formulated Alhydrogel competitive ELISA) method for direct quantification of OAg present in Shigella sonnei GMMA-based vaccine and its optimization using Design of Experiments approachFrancesca Necchi, Martina Carducci, Ivan Pisoni, et al.
Pageof 13

Showing results (21-30 of 122) with videos related to

Sort By:
Pageof 13
Methods in Molecular Biology (Clifton, N.J.)|August 6, 2005
Determining residual host cell antigen levels in purified recombinant proteins by slot blot and scanning laser densitometryAaron P Miles, Daming Zhu, Allan Saul
Statistics in Biopharmaceutical Research|September 12, 2009
Robust Non-inferiority Tests for Potency of a Test Drug Against a Reference Drug: (To appear in Statistics in Biopharmaceutical Research )Michael P Fay, Farzad Noubary, Allan Saul
Plos Neglected Tropical Diseases|January 6, 2017
A Systematic Review of the Incidence, Risk Factors and Case Fatality Rates of Invasive Nontyphoidal Salmonella (iNTS) Disease in Africa (1966 to 2014)Ifeanyi Valentine Uche, Calman A MacLennan, Allan Saul
Acta Crystallographica. Section D, Biological Crystallography|March 25, 2004
Crystallization and preliminary X-ray analysis of the Plasmodium vivax sexual stage 25 kDa protein Pvs25, a transmission-blocking vaccine candidate for malariaAjay K Saxena, Allan Saul, David N Garboczi
Bioconjugate Chemistry|November 10, 2015
Click Chemistry Applied to the Synthesis of Salmonella Typhimurium O-Antigen Glycoconjugate Vaccine on Solid Phase with Sugar RecyclingGiuseppe Stefanetti, Allan Saul, Calman A MacLennan, et al.
Protein Expression and Purification|June 20, 2002
Large-scale purification and characterization of malaria vaccine candidate antigen Pvs25H for use in clinical trialsAaron P Miles, Yanling Zhang, Allan Saul, et al.
BMC Infectious Diseases|June 2, 2022
The impact of three progressively introduced interventions on second wave daily COVID-19 case numbers in Melbourne, AustraliaAllan Saul, Nick Scott, Tim Spelman, et al.
High-Throughput|June 12, 2020
Intra-Laboratory Evaluation of Luminescence Based High-Throughput Serum Bactericidal Assay (L-SBA) to Determine Bactericidal Activity of Human Sera against <i>Shigella</i>Omar Rossi, Eleonora Molesti, Allan Saul, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 27, 2002
High diversity and rapid changeover of expressed var genes during the acute phase of Plasmodium falciparum infections in human volunteersJennifer Peters, Elizabeth Fowler, Michelle Gatton, et al.
Journal of Immunological Methods|May 1, 2019
Development of FAcE (Formulated Alhydrogel competitive ELISA) method for direct quantification of OAg present in Shigella sonnei GMMA-based vaccine and its optimization using Design of Experiments approachFrancesca Necchi, Martina Carducci, Ivan Pisoni, et al.
Pageof 13